RET gene abnormalities and thyroid disease: who should be screened and when
about
Horizon scanning for translational genomic research beyond bench to bedside.Quantitative analysis of receptor tyrosine kinase-effector coupling at functionally relevant stimulus levels.A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma.Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
P2860
RET gene abnormalities and thyroid disease: who should be screened and when
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
RET gene abnormalities and thyroid disease: who should be screened and when
@ast
RET gene abnormalities and thyroid disease: who should be screened and when
@en
RET gene abnormalities and thyroid disease: who should be screened and when
@nl
type
label
RET gene abnormalities and thyroid disease: who should be screened and when
@ast
RET gene abnormalities and thyroid disease: who should be screened and when
@en
RET gene abnormalities and thyroid disease: who should be screened and when
@nl
prefLabel
RET gene abnormalities and thyroid disease: who should be screened and when
@ast
RET gene abnormalities and thyroid disease: who should be screened and when
@en
RET gene abnormalities and thyroid disease: who should be screened and when
@nl
P2860
P921
P356
P1476
RET gene abnormalities and thyroid disease: who should be screened and when
@en
P2093
Behrouz Salehian
Raynald Samoa
P2860
P356
10.4274/JCRPE.870
P407
P478
P5008
P577
2013-01-01T00:00:00Z